{"id":"W2955031471","doi":"10.1161/circulationaha.119.039609","title":"Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease","year":2019,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"ca_institutions":"Population Health Research Institute","funders":"Idorsia Pharmaceuticals; Servier; Eisai; Belvoir Media Group; Duke Clinical Research Institute; Novo Nordisk; Medicines Company; St. Jude Medical; Regeneron Pharmaceuticals; Amarin Corporation; Boston Scientific Corporation; Daiichi Sankyo Europe; Sanofi; Amgen; Pfizer; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Ironwood Pharmaceuticals, Incorporated","keywords":"Medicine; Rivaroxaban; Aspirin; Internal medicine; Heart failure; Myocardial infarction; Coronary artery disease; Cardiology; Stroke (engine); Ejection fraction; Adverse effect; Hazard ratio; Warfarin; Atrial fibrillation; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002369116,0.0003479228,0.001200807,0.0003175179,0.0003696317,0.0005941805,0.000272376,0.0007379903,0.002363804],"category_scores_gemma":[0.003351921,0.0001934724,0.001002396,0.0006287187,0.0003028174,0.0003933108,0.0004032095,0.0006613655,0.0002709192],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002994344,"about_ca_system_score_gemma":0.000900853,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007083656,"about_ca_topic_score_gemma":0.001342838,"domain_scores_codex":[0.9984301,0.0007867937,0.0001959127,0.0002256387,0.0001987752,0.0001627442],"domain_scores_gemma":[0.9988809,0.0004323595,0.0003435341,0.00006516984,0.00006759036,0.000210355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3072025,0.006180709,0.454845,0.004139065,0.008195266,0.0009732175,0.0003399797,0.000740005,0.003178346,0.0007393609,0.008156767,0.2053098],"study_design_scores_gemma":[0.1816514,0.0999466,0.6851493,0.001097842,0.005995677,0.002415075,0.0002498368,0.001273684,0.0005690624,0.00146151,0.02013347,0.00005643979],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9463274,0.04420072,0.0004730811,0.002091048,0.0005303428,0.0005204594,0.000831029,0.00002050531,0.005005436],"genre_scores_gemma":[0.9889364,0.006957879,0.0005378825,0.00148909,0.0006424004,0.00046061,0.000518409,0.000003932896,0.0004534289],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002369116,"threshold_uncertainty_score":0.01252925,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01931170759897828,"score_gpt":0.2660936462790983,"score_spread":0.24678193868012,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}